Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1976 Mar;57(3):714–721. doi: 10.1172/JCI108329

Serum lipoproteins and apolipoproteins in rats with streptozotocin-induced diabetes.

H Bar-On, P S Roheim, H A Eder
PMCID: PMC436706  PMID: 175093

Abstract

The lipoproteins of rats fed a high sucrose diet and made diabetic by administration of 45 mg/kg of streptozotocin were studied. All lipoprotein classes were found to be present in increased concentrations. The apolipoprotein composition of the various lipoprotein fractions was studied by polyacrylamide-gel electrophoresis in the presence of 8 M urea, isoelectric focusing in the presence of 8 M urea, and sodium dodecyl sulfate gel electrophoresis in polyacrylamide gels. In the very low density lipoproteins (VLDL) of diabetic rats, there was a marked alteration in the relative amounts of C proteins by polyacrylamide-gel electrophoresis, and this was found by isoelectric focusing to be primarily a relative increase in C-III-3 apoprotein and a decrease in C-III-O. In addition, in the diabetic rats, the VLDL contained a protein of mol wt 46,000, the A-IV protein, which normally is only present in the high density lipoproteins. In the high density lipoproteins, (HDL) the same alterations in pattern of the C proteins seen in the VLDL were present. Furthermore, the arginine-rich and A-IV protein normally present in HDL could not be detected in the HDL, although the other apolipoproteins are present. Apolipoprotein concentrations were determined by quantitative immunoelectrophoresis. It was found that in the diabetic rats there was an increase in the total amount of apo-B in the plasma, with the increment divided proportionately between the VLDL and the low density lipoprotein (LDL). The total apo-C concentration of plasma increased minimally. The A-IV concentration of plasma increased by 27%; it decreased markedly in the HDL, but appeared in increased amounts in both VLDL and in the d greater than 1.21 fraction. The arginine-rich protein decreased by 63% in the plasma and decreased significantly in the HDL, but increased in VLDL, LDL, and in the d greater than 1.21 fraction. These alterations in apolipoprotein patterns in diabetic animals suggest that the apolipoproteins may play an important role in determining the concentration of various lipoprotein fractions, or may be the result of altered metabolism of the lipoproteins. These lipoproteins with altered apolipoprotein composition may have important biologic differences from normal lipoporteins. Nevertheless, the HDL, despite the fact that it is deficient in some of its major constituents, was unchanged in its cholesterol content.

Full text

PDF
714

Images in this article

717Image
on p.717
717Image
on p.717
717Image
on p.717
717Image
on p.717
718Image
on p.718
718Image
on p.718
718Image
on p.718
718Image
on p.718
719Image
on p.719

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABEL L. L., LEVY B. B., BRODIE B. B., KENDALL F. E. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem. 1952 Mar;195(1):357–366. [PubMed] [Google Scholar]
  2. Bersot T. P., Brown W. V., Levy R. I., Windmueller H. G., Fredrickson D. S., LeQuire V. S. Further characterization of the apolipoproteins of rat plasma lipoproteins. Biochemistry. 1970 Aug 18;9(17):3427–3433. doi: 10.1021/bi00819a022. [DOI] [PubMed] [Google Scholar]
  3. Bilheimer D. W., Eisenberg S., Levy R. I. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta. 1972 Feb 21;260(2):212–221. doi: 10.1016/0005-2760(72)90034-3. [DOI] [PubMed] [Google Scholar]
  4. Brown W. V., Baginsky M. L. Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. Biochem Biophys Res Commun. 1972 Jan 31;46(2):375–382. doi: 10.1016/s0006-291x(72)80149-9. [DOI] [PubMed] [Google Scholar]
  5. Brown W. V., Levy R. I., Fredrickson D. S. Studies of the proteins in human plasma very low density lipoproteins. J Biol Chem. 1969 Oct 25;244(20):5687–5694. [PubMed] [Google Scholar]
  6. Glickman R. M., Kirsch K. Lymph chylomicron formation during the inhibition of protein synthesis. Studies of chylomicron apoproteins. J Clin Invest. 1973 Nov;52(11):2910–2920. doi: 10.1172/JCI107487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Havel R. J., Kane J. P. Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins. Proc Natl Acad Sci U S A. 1973 Jul;70(7):2015–2019. doi: 10.1073/pnas.70.7.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Havel R. J., Shore V. G., Shore B., Bier D. M. Role of specific glycopeptides of human serum lipoproteins in the activation of lipoprotein lipase. Circ Res. 1970 Oct;27(4):595–600. doi: 10.1161/01.res.27.4.595. [DOI] [PubMed] [Google Scholar]
  10. Herbert P. N., Windmueller H. G., Bersot T. P., Shulman R. S. Characterization of the rat apolipoproteins. I. The low molecular weight proteins of rat plasma high density lipoproteins. J Biol Chem. 1974 Sep 25;249(18):5718–5724. [PubMed] [Google Scholar]
  11. Koga S., Bolis L., Scanu A. M. Isolation and characterization of subunit polypeptides from apoproteins of rat serum lipoprotein. Biochim Biophys Acta. 1971 May 25;236(2):416–430. doi: 10.1016/0005-2795(71)90222-4. [DOI] [PubMed] [Google Scholar]
  12. Koga S., Horwitz D. L., Scanu A. M. Isolation and properties of lipoproteins from normal rat serum. J Lipid Res. 1969 Sep;10(5):577–588. [PubMed] [Google Scholar]
  13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  14. LaRosa J. C., Levy R. I., Herbert P., Lux S. E., Fredrickson D. S. A specific apoprotein activator for lipoprotein lipase. Biochem Biophys Res Commun. 1970 Oct 9;41(1):57–62. doi: 10.1016/0006-291x(70)90468-7. [DOI] [PubMed] [Google Scholar]
  15. Lasser N. L., Roheim P. S., Edelstein D., Eder H. A. Serum lipoproteins of normal and cholesterol-fed rats. J Lipid Res. 1973 Jan;14(1):1–8. [PubMed] [Google Scholar]
  16. Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966 Apr;15(1):45–52. doi: 10.1016/0003-2697(66)90246-6. [DOI] [PubMed] [Google Scholar]
  17. Malik N., Berrie A. New stain fixative for proteins separated by gel isoelectric focusing based on Coomassie Brilliant Blue. Anal Biochem. 1972 Sep;49(1):173–176. doi: 10.1016/0003-2697(72)90255-2. [DOI] [PubMed] [Google Scholar]
  18. ROHEIM P. S., MILLER L., EDER H. A. THE FORMATION OF PLASMA LIPOPROTEINS FROM APOPROTEIN IN PLASMA. J Biol Chem. 1965 Jul;240:2994–3001. [PubMed] [Google Scholar]
  19. Reaven E. P., Reaven G. M. Mechanisms for development of diabetic hypertriglyceridemia in streptozotocin-treated rats. Effect of diet and duration of insulin deficiency. J Clin Invest. 1974 Nov;54(5):1167–1178. doi: 10.1172/JCI107860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Reisfeld R. A., Small P. A., Jr Electrophoretic heterogeneity of polypeptide chains of specific antibodies. Science. 1966 May 27;152(3726):1253–1255. doi: 10.1126/science.152.3726.1253. [DOI] [PubMed] [Google Scholar]
  21. Sata T., Havel R. J., Jones A. L. Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans. J Lipid Res. 1972 Nov;13(6):757–768. [PubMed] [Google Scholar]
  22. Scanu A. M., Edelstein C. Solubility in aqueous solutions of ethanol of the small molecular weight peptides of the serum very low density and high density lipoproteins: relevance to the recovery problem during delipidation of serum lipoproteins. Anal Biochem. 1971 Dec;44(2):576–588. doi: 10.1016/0003-2697(71)90247-8. [DOI] [PubMed] [Google Scholar]
  23. Scanu A., Toth J., Edelstein C., Koga S., Stiller E. Fractionation of human serum high density lipoprotein in urea solutions. Evidence for polypeptide heterogeneity. Biochemistry. 1969 Aug;8(8):3309–3316. doi: 10.1021/bi00836a027. [DOI] [PubMed] [Google Scholar]
  24. Schein P. S., Alberti K. G., Williamson D. H. Effects of streptozotocin on carbohydrate and lipid metabolism in the rat. Endocrinology. 1971 Sep;89(3):827–834. doi: 10.1210/endo-89-3-827. [DOI] [PubMed] [Google Scholar]
  25. Schonfeld G., Birge C., Miller J. P., Kessler G., Santiago J. Apolipoprotein B levels and altered lipoprotein composition in diabetes. Diabetes. 1974 Oct;23(10):827–834. doi: 10.2337/diab.23.10.827. [DOI] [PubMed] [Google Scholar]
  26. Seidel D., Alaupovic P., Furman R. H., McConathy W. J. A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins. J Clin Invest. 1970 Dec;49(12):2396–2407. doi: 10.1172/JCI106459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Shapiro A. L., Viñuela E., Maizel J. V., Jr Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels. Biochem Biophys Res Commun. 1967 Sep 7;28(5):815–820. doi: 10.1016/0006-291x(67)90391-9. [DOI] [PubMed] [Google Scholar]
  28. Shore B., Shore V. An apolipoprotein preferentially enriched in cholesteryl ester-rich very low density lipoproteins. Biochem Biophys Res Commun. 1974 May 7;58(1):1–7. doi: 10.1016/0006-291x(74)90882-1. [DOI] [PubMed] [Google Scholar]
  29. Shore B., Shore V. Heterogeneity in protein subunits of human serum high-density lipoproteins. Biochemistry. 1968 Aug;7(8):2773–2777. doi: 10.1021/bi00848a011. [DOI] [PubMed] [Google Scholar]
  30. Shore V. G., Shore B., Hart R. G. Changes in apolipoproteins and properties of rabbit very low density lipoproteins on induction of cholesteremia. Biochemistry. 1974 Apr 9;13(8):1579–1585. doi: 10.1021/bi00705a004. [DOI] [PubMed] [Google Scholar]
  31. Spiro R. G. Glycoproteins. Adv Protein Chem. 1973;27:349–467. doi: 10.1016/s0065-3233(08)60451-9. [DOI] [PubMed] [Google Scholar]
  32. Swaney J. B., Reese H., Eder H. A. Polypeptide composition of rat high density lipoprotein: characterization by SDS-gel electrophoresis. Biochem Biophys Res Commun. 1974 Jul 24;59(2):513–519. doi: 10.1016/s0006-291x(74)80010-0. [DOI] [PubMed] [Google Scholar]
  33. Vaitukaitis J., Robbins J. B., Nieschlag E., Ross G. T. A method for producing specific antisera with small doses of immunogen. J Clin Endocrinol Metab. 1971 Dec;33(6):988–991. doi: 10.1210/jcem-33-6-988. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES